Association of Skeletal Muscle Function Deficit (SMFD) with Performance, Disability, Frailty Phenotype, Hospitalization, and Falls: Results from the InCHIANTI Study
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Age-related muscle dysfunction is a major contributor to disability, frailty, and poor clinical outcomes in older adults. Muscle mass and strength provide limited insight into the multifactorial nature of muscular decline. Skeletal Muscle Function Deficit (SMFD) framework integrates multiple domains muscle mass, quality, strength, and power to capture a broader spectrum of age-related muscle dysfunction.
Objective
To develop and validate a composite SMFD score and evaluate its association with key geriatric outcomes in older adults.
Methods
This study used data from the InCHIANTI longitudinal cohort (1998–2018), including 1,035 participants and 3,196 total assessments. The SMFD score (range 0–20) was computed by assigning quintile-based values of muscle area, density, strength, and lower limb power. Associations with disability in basic and instrumental activities of daily living (BADL/IADL), frailty phenotype, poor physical performance (SPPB <7), hospitalization, falls number, and major chronic diseases were analyzed using mixed-effects models, adjusting for age, sex, fat area, and multimorbidity.
Results
The SMFD score declined significantly over time and was independently associated with lower risk of BADL (OR 0.57), IADL (OR 0.70), frailty (OR 0.72), poor performance (OR 0.68), hospitalization (OR 0.96), and falls number (OR 0.96). Higher SMFD scores were also inversely associated with the prevalence and incidence of Parkinson’s disease, stroke, and hip osteoarthritis.
Conclusions
The SMFD score is a valid, multidimensional measure that predicts adverse outcomes in older adults more effectively than traditional sarcopenia, dynapenia, and powerpenia. It holds promise for use in clinical assessment, risk stratification, and targeted interventions.
